Cure One has joined the INNODIA network, a leading collaborative initiative bringing together researchers, clinical centres, industry partners and patient organisations to accelerate type 1 diabetes research. Following a successful qualification process and site visit, Cure One has officially become part of the network. Joining INNODIA strengthens our international collaborations and creates new opportunities to exchange knowledge, participate in collaborative research initiatives, and accelerate innovation in type 1 diabetes research. Together with partners across Europe, we are committed to advancing research and bringing the goal of curing type 1 diabetes closer to reality.